Unique immune response in lupus paves the way for new treatments
October 16, 2024
October 16, 2024
ITHACA, New York, Oct. 16 -- Cornell University issued the following news:
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1b) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell Medicine investigators.
The findings, published Oct. 7 in Immunity, could lead to new treatments targeting IL-1b to better manage inflammation in . . .
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1b) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell Medicine investigators.
The findings, published Oct. 7 in Immunity, could lead to new treatments targeting IL-1b to better manage inflammation in . . .